Groww Logo
Home>US Stocks>United Therapeutics Corporation

United Therapeutics Corporation

Healthcare
$228.39
+ $9.44 (4.31%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Today’s Low
$
    Today’s High
    $
    52W Low
    $
      52W High
      $
      Open PricePrev. CloseVolumeAvg. Volume
      $219.99$228.39828,026470,229

      Fundamentals

      Market Cap$10.34B
      P/B Ratio2.5
      P/E Ratio15.1
      Enterprise Value$10.33B
      Div. Yield0.00%
      Book Value92.40
      EPS(TTM)15.26
      ROE17.60%
      Understand Fundamentals

      Company Financials

      *All values are in Million $
      No Graph Data To Display
      Quarterly
      Yearly
      See Details

      FAQs on United Therapeutics Corporation

      Can I Buy United Therapeutics Corporation Shares in India?

      Yes, United Therapeutics Corporation shares can be bought in India by opening an international trading account with Groww.

      How to Buy United Therapeutics Corporation Shares in India?

      One can easily invest in United Therapeutics Corporation shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy United Therapeutics Corporation shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of United Therapeutics Corporation.

      What is the Share Price of United Therapeutics Corporation?

      The share price of United Therapeutics Corporation is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current United Therapeutics Corporation share price is $228.39 as of 26 May ‘22

      What is the Market Cap of United Therapeutics Corporation?

      The United Therapeutics Corporation market cap is $10.34B as of 26 May ‘22

      What is the PE and PB ratio of United Therapeutics Corporation?

      The PE and PB ratio of United Therapeutics Corporation is 15.1 and 2.5 as of 26 May ‘22
      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 2.4.0
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

      ABOUT GROWW